Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Photocure ASA : Mandatory notification of trade

03/22/2013 | 05:02am US/Eastern
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

distributed by
React to this article
Latest news on PHOTOCURE ASA
08/26 BIOSYENT : Pharma Gets Exclusive Rights for Cysview in Canada
08/25 PHOTOCURE ASA : Presentation at the Pareto Securities' 6th Annual Health Care Se..
08/24 BIOSYENT : Pharma Gets Exclusive Rights for Cysview in Canada
08/20 BIOSYENT : Pharma Enters into Licensing Agreement with Photocure for Cysview
08/19 PHOTOCURE ASA : announces Biosyent as exclusive partner for Cysview® in Canada
08/13 PHOTOCURE ASA : Results for second quarter and the first half year 2015
08/13 PHOTOCURE ASA : Results for second quarter and the first half year 2015
08/10 PHOTOCURE ASA : Announces agreement with us fda for cevira phase 3 registration ..
08/06 PHOTOCURE ASA : Presentation of the second quarter and first half-year 2015 resu..
08/06 PHOTOCURE ASA : Correction - Photocure ASA: Presentation of the second quarter a..
Advertisement
Chart
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Income Statement Evolution
More Financials